Effect of prior chemotherapy on hematopoietic stem cell mobilization.

Effect of prior chemotherapy on hematopoietic stem cell mobilization.

Item
http://www.wikidata.org/entity/Q44788991
European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization.Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model.Potential for a pluripotent adult stem cell treatment for acute radiation sickness.Increased mobilization and yield of stem cells using plerixafor in combination with granulocyte-colony stimulating factor for the treatment of non-Hodgkin's lymphoma and multiple myeloma.Pegfilgrastim vs filgrastim in PBSC mobilization for autologous hematopoietic SCT: a systematic review and meta-analysis.Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean mulCD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony-stimulating factor.Factors affecting autologous peripheral blood hematopoietic stem cell collections by large-volume leukapheresis: a single center experience.Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group.Plerixafor to the rescue: boosting peripheral blood stem cell mobilization in patients previously treated with hyperfractionated cyclophosphamide, vincristine, doxorubicin, dexamethasone/methotrexate, cytarabine (Hyper-CVAD) chemotherapy.Plerixafor is effective and safe for stem cell mobilization in heavily pretreated germ cell tumor patients.ESHAP + fixed dose G-CSF as autologous peripheral blood stem cell mobilization regimen in patients with relapsed or refractory diffuse large cell and Hodgkin's lymphoma: a single institution result of 127 patients.Plerixafor plus G-CSF in combination with chemotherapy for stem cell mobilization in a pediatric patient with Ewing's sarcoma.An analysis of the optimal timing of peripheral blood stem cell harvesting following priming with cyclophosphamide and G-CSF.Bendamustine and stem-cell mobilization: not so bad!Correlation between serum lactate dehydrogenase and stem cell mobilization.
P2860

Effect of prior chemotherapy on hematopoietic stem cell mobilization.

Item
http://www.wikidata.org/entity/Q44788991
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Effect of prior chemotherapy on hematopoietic stem cell mobilization.
@en
Effect of prior chemotherapy on hematopoietic stem cell mobilization.
@nl
type
label
Effect of prior chemotherapy on hematopoietic stem cell mobilization.
@en
Effect of prior chemotherapy on hematopoietic stem cell mobilization.
@nl
prefLabel
Effect of prior chemotherapy on hematopoietic stem cell mobilization.
@en
Effect of prior chemotherapy on hematopoietic stem cell mobilization.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Effect of prior chemotherapy on hematopoietic stem cell mobilization.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921